Publications

Urban J, Fitzgerald L, Burkhalter B, Staskal D, Harris M, Haws L. BTEX serum levels in the general U.S. population: An analysis of 2003-2004 NHANES dataset. Presented at Society of Toxicology 50th Annual Meeting, Washington, D.C., March 2011.

Diliberto JJ, Sirinek L, Burkhalter B, Wikoff DS, Hixon G, Becker J, Patterson DG, Turner W, Tachovsky JA, Birnbaum LS, Haws LC. Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Oller A, Henderson RG. Bioaccessibility testing and its application to read-across for hazard assessment and risk characterisation of metals. Annual Meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox), 2011.

Haws LC, DeVito MJ, Walker NJ,Harris MA, Tachovsky JA, Birnbaum LS, Farland WH, Wikoff DS. Development of a consensus-based weighting framework for evaluating estimates of relative potency for dioxin-like compounds that includes consideration of data from human cells. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Semeraro A, Patriarca M, Taylor A, Henderson R, Bates H. Nickel kinetics after oral exposure: Urinary excretion. IUPAC 4th International Symposium for Trace Elements in Food, 2011.

Vivanco S. IVAN’s effectiveness in identifying and addressing environmental harms in underserved communities. University of California, Los Angeles Fielding School of Public Health Graduate Seminar, Los Angeles, CA, Fall 2011.

Haws LC, Fitzgerald L, Burkhalter B, Harris M, Wikoff DS. Assessment of the US EPA’s proposed toxicological values for TCDD for regulation of dioxin-like compounds in foods: Bridging the science divide in a global market. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastases among breast, lung, and prostate cancer patients. Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 2011.

Rowlands JC, Urban J, Wikoff DS, Budinsky R. The presence and estimated functional effect of single nucleotide polymorphisms at the AIP, ARNT, HSP90AA1, AND HSP90AB1 loci in the human population. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Willems SS, Sheppard AM, Treichel JL, Raabe H, Curren R. An evaluation of the reconstructed human epidermis (RhE) method for predicting skin corrosivity of chemical products with extreme acid pH. World Congress, Canada, 2011.

Kreider ML, Panko JM, McDonald JD, McAtee BL, Finley BL, Seagrave J. Effects of intratracheal instillation of tire and road wear particles (TRWP) and tread particles (TP) on inflammation and cytotoxicity in rat lung: A comparative toxicity study. Society of Toxicology Annual Meeting, Washington, D.C., 2011.

Grespin ME, Le MH, Panko JM. Safety data sheet alteration during alignment with the Globally Harmonized System of Classification (GHS) and implications for chemical manufacturers, suppliers and distributors. Society for Risk Analysis Annual Meeting, Charleston, SC, December 2011.

Hitchcock KM, Panko JM, Scott PK. The chemical footprint: An emerging indicator of environmental performance. Society for Environmental Toxicology and Chemistry, Boston, MA, November 2011.

Thomas RS, Rowlands JC, Budinsky RA, Thompson CM, Urban JD. Dombkowski, A. 2011. Genomic approaches for relative potency assessment. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Wikoff DS, Thompson C, Walker N, DeVito M, Harris M, Birnbaum L, Haws L. Derivation of relative potency estimates using benchmark dose modeling: A case study with TCDF. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Budinsky R, Urban J, Rowlands JC. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator gene. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Mitchell M, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of pediatric acute lymphoblastic leukemia (pALL). Presented at the American Society for Pediatric Hematology Oncology, Baltimore, MD, April 2011

Ceder R, Merne M, Nilsson J-A, Staab C, Höög J-O, Thompson CM, Grafström RC. Toxicogenomic profiling of formaldehyde-exposed normal and transformed human oral keratinocytes. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Covington T, Robinson P, Gearhart J. Exploring issues in simulating dermal exposure using a physiologically-based pharmacokinetic-pharmacodynamic (PBPK-PD) model for VX. Poster presented at the Society of Toxicology Annual Meeting, Washington, DC, March 2011.

Fitzgerald L, Burkhalter B, Urban J, Staskal D, Harris M, Haws L. VOC serum levels in the general U.S. population: An analysis of the 2003-2004 NHANES dataset. Presented at Society of Toxicology 50th Annual Meeting, Washington, D.C., March 2011